Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 7
Encontrada(s) 1 página(s)

Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Human pancreatic islet three-dimensional chromatin architecture provides insights into the genetics of type 2 diabetes

  • Miguel Escalada, Irene
  • Bonàs-Guarch, Silvia
  • Mendieta Esteban, Julen, 1992-
  • Atla, Goutham
  • Farabella, Irene
  • Morgan, Claire C.
  • García-Hurtado, Javier
  • Morán, Ignasi
  • Torrents, David
  • Mercader Bigas, Josep Maria
  • Marti-Renom, Marc A.
  • Ferrer, Jorge
Genetic studies promise to provide insight into the molecular mechanisms underlying type 2 diabetes (T2D). Variants associated with T2D are often located in tissue-specific enhancer clusters or super-enhancers. So far, such domains have been defined through clustering of enhancers in linear genome maps rather than in three-dimensional (3D) space. Furthermore, their target genes are often unknown. We have created promoter capture Hi-C maps in human pancreatic islets. This linked diabetes-associated enhancers to their target genes, often located hundreds of kilobases away. It also revealed >1,300 groups of islet enhancers, super-enhancers and active promoters that form 3D hubs, some of which show coordinated glucose-dependent activity. We demonstrate that genetic variation in hubs impacts insulin secretion heritability, and show that hub annotations can be used for polygenic scores that predict T2D risk driven by islet regulatory variants. Human islet 3D chromatin architecture, therefore, provides a framework for interpretation of T2D genome-wide association study (GWAS) signals., This research was supported by the National Institute for Health Research Imperial Biomedical Research Centre. Work was funded by grants from the Wellcome Trust (nos. WT101033 to J.F. and WT205915 to I.P.), Horizon 2020 (Research and Innovation Programme nos. 667191, to J.F., 633595, to I.P., and 676556, to M.A.M.-R.; Marie Sklodowska-Curie 658145, to I.M.-E., and 43062 ZENCODE, to G.A.), European Research Council (nos. 789055, to J.F., and 609989, to M.A.M.-R.). Marató TV3 (no. 201611, to J.F. and M.A.M.-R.), Ministerio de Ciencia Innovación y Universidades (nos. BFU2014-54284-R, RTI2018-095666, to J.F., BFU2017-85926-P, to M.A.M.-R., IJCI-2015-23352, to I.F.), AGAUR (to M.A.M.-R.). UK Medical Research Council (no. MR/L007150/1, to P.F., MR/L02036X/1 to J.F.), World Cancer Research Fund (WCRF UK, to I.P.) and World Cancer Research Fund International (no. 2017/1641 to I.P.), Biobanking and Biomolecular Resources Research Infrastructure (nos. BBMRI-NL, NWO 184.021.007, to I.O.F.). Work in IDIBAPS, CRG and CNAG was supported by the CERCA Programme, Generalitat de Catalunya and Centros de Excelencia Severo Ochoa (no. SEV-2012-0208). Human islets were provided through the European islet distribution program for basic research supported by JDRF (no. 3-RSC-2016-160-I-X). We thank N. Ruiz-Gomez for technical assistance; R. L. Fernandes, T. Thorne (University of Reading) and A. Perdones-Montero (Imperial College London) for helpful discussions regarding Machine Learning approaches; B. Lenhard and M. Merkenschlager (London Institute of Medical Sciences, Imperial College London), F. Müller (University of Birmingham) and J. L. Gómez-Skarmeta (Centro Andaluz de Biología del Desarrollo) for critical comments on the draft; the CRG Genomics Unit; and the Imperial College High Performance Computing Service.
Dipòsit Digital de la UB
Publication Artículo científico (JournalArticle)

Re-analysis of public genetic data reveals a rare X-chromosomal variant associated with type 2 diabetes

  • Bonàs Guarch, Sílvia
  • Guindo Martínez, Marta
  • Miguel-Escalada, Irene
  • Grarup, Niels
  • Sebastián Muñoz, David
  • Rodriguez-Fos, Elias
  • Sánchez, Friman
  • Planas-Fèlix, Mercè
  • Cortes-Sánchez, Paula
  • González, Santi
  • Timshel, Pascal
  • Pers, Tune H.
  • Morgan, Claire C.
  • Moran, Ignasi
  • Atla, Goutham
  • González, Juan Ramón
  • Puiggròs, Montserrat
  • Martí, Jonathan
  • Andersson, Ehm A.
  • Díaz, Carlos
  • Badia, Rosa M.
  • Udler, Miriam
  • Leong, Aaron
  • Kaur, Varindepal
  • Flannick, Jason
  • Jørgensen, Torben
  • Linneberg, Allan
  • Jørgensen, Marit E.
  • Witte, Daniel R.
  • Christensen, Cramer
  • Brandslund, Ivan
  • Appel, Emil V.
  • Scott, Robert A.
  • Luan, Jian'an
  • Langenberg, Claudia
  • Wareham, Nicholas J.
  • Pedersen, Oluf
  • Zorzano Olarte, Antonio
  • Florez, Jose C.
  • Hansen, Torben
The reanalysis of existing GWAS data represents a powerful and cost-effective opportunity to gain insights into the genetics of complex diseases. By reanalyzing publicly available type 2 diabetes (T2D) genome-wide association studies (GWAS) data for 70,127 subjects, we identify seven novel associated regions, five driven by common variants (LYPLAL1, NEUROG3, CAMKK2, ABO, and GIP genes), one by a low-frequency (EHMT2), and one driven by a rare variant in chromosome Xq23, rs146662057, associated with a twofold increased risk for T2D in males. rs146662057 is located within an active enhancer associated with the expression of Angiotensin II Receptor type 2 gene (AGTR2), a modulator of insulin sensitivity, and exhibits allelic specific activity in muscle cells. Beyond providing insights into the genetics and pathophysiology of T2D, these results also underscore the value of reanalyzing publicly available data using novel genetic resources and analytical approaches.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Re-analysis of public genetic data reveals a rare X-chromosomal variant associated with type 2 diabetes

  • Bonàs-Guarch, Silvia
  • Guindo-Martínez, M.
  • Miguel-Escalada, I.
  • Niels Grarup
  • Sebastian, David
  • Rodriguez-Fos, Elias
  • Sánchez, Friman
  • Planas-Fèlix, Mercè
  • Cortes-Sánchez, Paula
  • González, Santi
  • Timshel, Pascal
  • Pers, Tune H.
  • Morgan, Claire C.
  • Morán, Ignasi
  • Atla, Goutham
  • González, Juan R.
  • Puiggros, Montserrat
  • Martí, Jonathan
  • Andersson, Ehm A.
  • Díaz, Carlos
  • Badia, Rosa M.
  • Udler, Miriam
  • Leong, Aaron
  • Kaur, Varindepal
  • Flannick, Jason
  • Jørgensen, Torben
  • Linneberg, Allan
  • Jørgensen, Marit E.
  • Witte, Daniel R.
  • Christensen, Cramer
  • Brandslund, Ivan
  • Appel, Emil V.
  • Scott, Robert A.
  • Luan, Jian’an
  • Langenberg, Claudia
  • Wareham, Nicholas J.
  • Pedersen, Oluf
  • Zorzano, Antonio
  • Florez, Jose C.
  • Hansen, Torben
  • Ferrer, Jorge
  • Mercader, Josep Maria
  • Torrents, David
The reanalysis of existing GWAS data represents a powerful and cost-effective opportunity to gain insights into the genetics of complex diseases. By reanalyzing publicly available type 2 diabetes (T2D) genome-wide association studies (GWAS) data for 70,127 subjects, we identify seven novel associated regions, five driven by common variants (LYPLAL1, NEUROG3, CAMKK2, ABO, and GIP genes), one by a low-frequency (EHMT2), and one driven by a rare variant in chromosome Xq23, rs146662057, associated with a twofold increased risk for T2D in males. rs146662057 is located within an active enhancer associated with the expression of Angiotensin II Receptor type 2 gene (AGTR2), a modulator of insulin sensitivity, and exhibits allelic specific activity in muscle cells. Beyond providing insights into the genetics and pathophysiology of T2D, these results also underscore the value of reanalyzing publicly available data using novel genetic resources and analytical approaches., This work has been sponsored by the grant SEV-2011-00067 of Severo Ochoa Program, awarded by the Spanish Government. This work was supported by an EFSD/Lilly research fellowship. Josep M. Mercader was supported by Sara Borrell Fellowship from the Instituto Carlos III and Beatriu de Pinós fellowship from the Agency for Management of University and Research Grants (AGAUR). Sílvia Bonàs was FI-DGR Fellowship from FI-DGR 2013 from Agència de Gestió d’Ajuts Universitaris i de Recerca (AGAUR, Generalitat de Catalunya). This study makes use of data generated by the WTCCC. A full list of the investigators who contributed to the generation of the data is available from www.wtccc.org.uk. Funding for the project was provided by the Wellcome Trust under award 076113. This study also makes use of data generated by the UK10K Consortium, derived from samples from UK10K COHORT IMPUTATION (EGAS00001000713). A full list of the investigators who contributed to the generation of the data is available in www.UK10K.org. Funding for UK10K was provided by the Wellcome Trust under award WT091310. We acknowledge PRACE for awarding us to access MareNostrum supercomputer, based in Spain at Barcelona. The technical support group, particularly Pablo Ródenas and Jorge Rodríguez, from the Barcelona Supercomputing Center is gratefully acknowledged. This project has received funding from the European Union’s Horizon 2020 research and innovation program under grant agreement No 667191. Mercè Planas-Fèlix is funded by the Obra Social Fundación la Caixa fellowship under the Severo Ochoa 2013 program. Work from Irene Miguel-Escalada, Ignasi Moran, Goutham Atla, and Jorge Ferrer was supported by the National Institute for Health Research (NIHR) Imperial Biomedical Research Centre, the Wellcome Trust (WT101033), Ministerio de Economía y Competitividad (BFU2014-54284-R) and Horizon 2020 (667191). Irene Miguel-Escalada has received funding from the European Union’s Horizon 2020 research and innovation program under the Marie Sklodowska–Curie grant agreement No 658145. We acknowledge Prof. Giulio Cossu (Institute of Inflammation and Repair, University of Manchester) for providing the muscle myoblast cell line. We also acknowledge the InterAct and SIGMA Type 2 Diabetes Consortia for access to the data to replicate the rs146662075 variant. A full list of the investigators of the SIGMA Type 2 Diabetes and the InterAct consortia is provided in Supplementary Notes 3 and 4. The Novo Nordisk Foundation Center for Basic Metabolic Research is an independent research center at the University of Copenhagen partially funded by an unrestricted donation from the Novo Nordisk Foundation (www.metabol.ku.dk). This research has been conducted using the UK Biobank Resource (application number 16803). We also acknowledge Bianca C. Porneala, MS for his technical assistance in the collection and curation of the genotype and phenotype data from Partners Biobank. We also thank Marcin von Grotthuss for their support for uploading the summary statistics data to the Type 2 Diabetes Genetic Portal (AMP-T2D portal). Finally, we thank all the Computational Genomics group at the BSC for their helpful discussions and valuable comments on the manuscript., Peer reviewed
UPCommons. Portal del coneixement obert de la UPC
Publication Artículo científico (JournalArticle)

Re-analysis of public genetic data reveals a rare X-chromosomal variant associated with type 2 diabetes

  • Bonàs-Guarch, Sílvia
  • Guindo-Martínez, Marta
  • Miguel-Escalada, Irene
  • Grarup, Niels
  • Sebastian, David
  • Rodriguez-Fos, Elias
  • Sánchez, Friman
  • Planas-Fèlix, Mercè
  • Cortes-Sánchez, Paula
  • González, Santi
  • Timshel, Pascal
  • Pers, Tune H.
  • Morgan, Claire C.
  • Moran, Ignasi
  • Atla, Goutham
  • González, Juan R.
  • Puiggros, Montserrat
  • Martí, Jonathan
  • Andersson, Ehm A.
  • Díaz, Carlos
  • Badia Sala, Rosa Maria|||0000-0003-2941-5499
  • Udler, Miriam
  • Leong, Aaron
  • Kaur, Varindepal
  • Flannick, Jason
  • Jorgensen, Torben
  • Linneberg, Allan
  • Jorgensen, Marit E.
  • Witte, Daniel R.
  • Christensen, Cramer
  • Brandslund, Ivan
  • Appel, Emil V.
  • Scott, Robert A.
  • Luan, Jian' an
  • Langenberg, Claudia
  • Wareham, Nicholas J.
  • Pedersen, Oluf
  • Zorzano, Antonio
  • Florez, Jose C.
  • Hansen, Torben
  • Ferrer, Jorge
  • Mercader, Josep M.
  • Torrents, David
The reanalysis of existing GWAS data represents a powerful and cost-effective opportunity to gain insights into the genetics of complex diseases. By reanalyzing publicly available type 2 diabetes (T2D) genome-wide association studies (GWAS) data for 70,127 subjects, we identify seven novel associated regions, five driven by common variants (LYPLAL1, NEUROG3, CAMKK2, ABO, and GIP genes), one by a low-frequency (EHMT2), and one driven by a rare variant in chromosome Xq23, rs146662057, associated with a twofold increased risk for T2D in males. rs146662057 is located within an active enhancer associated with the expression of Angiotensin II Receptor type 2 gene (AGTR2), a modulator of insulin sensitivity, and exhibits allelic specific activity in muscle cells. Beyond providing insights into the genetics and pathophysiology of T2D, these results also underscore the value of reanalyzing publicly available data using novel genetic resources and analytical approaches., This work has been sponsored by the grant SEV-2011-00067 of Severo Ochoa Program, awarded by the Spanish Government. This work was supported by an EFSD/Lilly research fellowship. Josep M. Mercader was supported by Sara Borrell Fellowship from the Instituto Carlos III and Beatriu de Pinós fellowship from the Agency for Management of University and Research Grants (AGAUR). Sílvia Bonàs was FI-DGR Fellowship from FI-DGR 2013 from Agència de Gestió d’Ajuts Universitaris i de Recerca (AGAUR, Generalitat de Catalunya). This study makes use of data generated by the WTCCC. A full list of the investigators who contributed to the generation of the data is available from www.wtccc.org.uk. Funding for the project was provided by the Wellcome Trust under award 076113. This study also makes use of data generated by the UK10K Consortium, derived from samples from UK10K COHORT IMPUTATION (EGAS00001000713). A full list of the investigators who contributed to the generation of the data is available in www.UK10K.org. Funding for UK10K was provided by the Wellcome Trust under award WT091310. We acknowledge PRACE for awarding us to access MareNostrum supercomputer, based in Spain at Barcelona. The technical support group, particularly Pablo Ródenas and Jorge Rodríguez, from the Barcelona Supercomputing Center is gratefully acknowledged. This project has received funding from the European Union’s Horizon 2020 research and innovation program under grant agreement No 667191. Mercè Planas-Fèlix is funded by the Obra Social Fundación la Caixa fellowship under the Severo Ochoa 2013 program. Work from Irene Miguel-Escalada, Ignasi Moran, Goutham Atla, and Jorge Ferrer was supported by the National Institute for Health Research (NIHR) Imperial Biomedical Research Centre, the Wellcome Trust (WT101033), Ministerio de Economía y Competitividad (BFU2014-54284-R) and Horizon 2020 (667191). Irene Miguel-Escalada has received funding from the European Union’s Horizon 2020 research and innovation program under the Marie Sklodowska–Curie grant agreement No 658145. We acknowledge Prof. Giulio Cossu (Institute of Inflammation and Repair, University of Manchester) for providing the muscle myoblast cell line. We also acknowledge the InterAct and SIGMA Type 2 Diabetes Consortia for access to the data to replicate the rs146662075 variant. A full list of the investigators of the SIGMA Type 2 Diabetes and the InterAct consortia is provided in Supplementary Notes 3 and 4. The Novo Nordisk Foundation Center for Basic Metabolic Research is an independent research center at the University of Copenhagen partially funded by an unrestricted donation from the Novo Nordisk Foundation (www.metabol.ku.dk). This research has been conducted using the UK Biobank Resource (application number 16803). We also acknowledge Bianca C. Porneala, MS for his technical assistance in the collection and curation of the genotype and phenotype data from Partners Biobank. We also thank Marcin von Grotthuss for their support for uploading the summary statistics data to the Type 2 Diabetes Genetic Portal (AMP-T2D portal). Finally, we thank all the Computational Genomics group at the BSC for their helpful discussions and valuable comments on the manuscript., Peer Reviewed
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Re-analysis of public genetic data reveals a rare X-chromosomal variant associated with type 2 diabetes

  • Bonàs Guarch, Sílvia
  • Guindo Martínez, Marta
  • Miguel-Escalada, Irene
  • Grarup, Niels
  • Sebastián Muñoz, David
  • Rodriguez-Fos, Elias
  • Sánchez, Friman
  • Planas-Fèlix, Mercè
  • Cortes-Sánchez, Paula
  • González, Santi
  • Timshel, Pascal
  • Pers, Tune H.
  • Morgan, Claire C.
  • Moran, Ignasi
  • Atla, Goutham
  • González, Juan Ramón
  • Puiggròs, Montserrat
  • Martí, Jonathan
  • Andersson, Ehm A.
  • Díaz, Carlos
  • Badia, Rosa M.
  • Udler, Miriam
  • Leong, Aaron
  • Kaur, Varindepal
  • Flannick, Jason
  • Jørgensen, Torben
  • Linneberg, Allan
  • Jørgensen, Marit E.
  • Witte, Daniel R.
  • Christensen, Cramer
  • Brandslund, Ivan
  • Appel, Emil V.
  • Scott, Robert A.
  • Luan, Jian'an
  • Langenberg, Claudia
  • Wareham, Nicholas J.
  • Pedersen, Oluf
  • Zorzano Olarte, Antonio
  • Florez, Jose C.
  • Hansen, Torben
The reanalysis of existing GWAS data represents a powerful and cost-effective opportunity to gain insights into the genetics of complex diseases. By reanalyzing publicly available type 2 diabetes (T2D) genome-wide association studies (GWAS) data for 70,127 subjects, we identify seven novel associated regions, five driven by common variants (LYPLAL1, NEUROG3, CAMKK2, ABO, and GIP genes), one by a low-frequency (EHMT2), and one driven by a rare variant in chromosome Xq23, rs146662057, associated with a twofold increased risk for T2D in males. rs146662057 is located within an active enhancer associated with the expression of Angiotensin II Receptor type 2 gene (AGTR2), a modulator of insulin sensitivity, and exhibits allelic specific activity in muscle cells. Beyond providing insights into the genetics and pathophysiology of T2D, these results also underscore the value of reanalyzing publicly available data using novel genetic resources and analytical approaches.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Human pancreatic islet three-dimensional chromatin architecture provides insights into the genetics of type 2 diabetes

  • Miguel Escalada, Irene
  • Bonàs-Guarch, Silvia
  • Mendieta Esteban, Julen, 1992-
  • Atla, Goutham
  • Farabella, Irene
  • Morgan, Claire C.
  • García-Hurtado, Javier
  • Morán, Ignasi
  • Torrents, David
  • Mercader Bigas, Josep Maria
  • Marti-Renom, Marc A.
  • Ferrer, Jorge
Genetic studies promise to provide insight into the molecular mechanisms underlying type 2 diabetes (T2D). Variants associated with T2D are often located in tissue-specific enhancer clusters or super-enhancers. So far, such domains have been defined through clustering of enhancers in linear genome maps rather than in three-dimensional (3D) space. Furthermore, their target genes are often unknown. We have created promoter capture Hi-C maps in human pancreatic islets. This linked diabetes-associated enhancers to their target genes, often located hundreds of kilobases away. It also revealed >1,300 groups of islet enhancers, super-enhancers and active promoters that form 3D hubs, some of which show coordinated glucose-dependent activity. We demonstrate that genetic variation in hubs impacts insulin secretion heritability, and show that hub annotations can be used for polygenic scores that predict T2D risk driven by islet regulatory variants. Human islet 3D chromatin architecture, therefore, provides a framework for interpretation of T2D genome-wide association study (GWAS) signals., This research was supported by the National Institute for Health Research Imperial Biomedical Research Centre. Work was funded by grants from the Wellcome Trust (nos. WT101033 to J.F. and WT205915 to I.P.), Horizon 2020 (Research and Innovation Programme nos. 667191, to J.F., 633595, to I.P., and 676556, to M.A.M.-R.; Marie Sklodowska-Curie 658145, to I.M.-E., and 43062 ZENCODE, to G.A.), European Research Council (nos. 789055, to J.F., and 609989, to M.A.M.-R.). Marató TV3 (no. 201611, to J.F. and M.A.M.-R.), Ministerio de Ciencia Innovación y Universidades (nos. BFU2014-54284-R, RTI2018-095666, to J.F., BFU2017-85926-P, to M.A.M.-R., IJCI-2015-23352, to I.F.), AGAUR (to M.A.M.-R.). UK Medical Research Council (no. MR/L007150/1, to P.F., MR/L02036X/1 to J.F.), World Cancer Research Fund (WCRF UK, to I.P.) and World Cancer Research Fund International (no. 2017/1641 to I.P.), Biobanking and Biomolecular Resources Research Infrastructure (nos. BBMRI-NL, NWO 184.021.007, to I.O.F.). Work in IDIBAPS, CRG and CNAG was supported by the CERCA Programme, Generalitat de Catalunya and Centros de Excelencia Severo Ochoa (no. SEV-2012-0208). Human islets were provided through the European islet distribution program for basic research supported by JDRF (no. 3-RSC-2016-160-I-X). We thank N. Ruiz-Gomez for technical assistance; R. L. Fernandes, T. Thorne (University of Reading) and A. Perdones-Montero (Imperial College London) for helpful discussions regarding Machine Learning approaches; B. Lenhard and M. Merkenschlager (London Institute of Medical Sciences, Imperial College London), F. Müller (University of Birmingham) and J. L. Gómez-Skarmeta (Centro Andaluz de Biología del Desarrollo) for critical comments on the draft; the CRG Genomics Unit; and the Imperial College High Performance Computing Service.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Re-analysis of public genetic data reveals a rare X-chromosomal variant associated with type 2 diabetes

  • Bonàs-Guarch, Sílvia
  • Guindo-Martínez, Marta
  • Miguel-Escalada, Irene
  • Grarup, Niels
  • Sebastian, David
  • Rodriguez-Fos, Elias
  • Sánchez, Friman
  • Planas-Fèlix, Mercè
  • Cortes-Sánchez, Paula
  • González, Santi
  • Timshel, Pascal
  • Pers, Tune H.
  • Morgan, Claire C.
  • Moran, Ignasi
  • Atla, Goutham
  • González, Juan R.
  • Puiggros, Montserrat
  • Martí, Jonathan
  • Andersson, Ehm A.
  • Díaz, Carlos
  • Badia Sala, Rosa Maria
  • Udler, Miriam
  • Leong, Aaron
  • Kaur, Varindepal
  • Flannick, Jason
  • Jorgensen, Torben
  • Linneberg, Allan
  • Jorgensen, Marit E.
  • Witte, Daniel R.
  • Christensen, Cramer
  • Brandslund, Ivan
  • Appel, Emil V.
  • Scott, Robert A.
  • Luan, Jian' an
  • Langenberg, Claudia
  • Wareham, Nicholas J.
  • Pedersen, Oluf
  • Zorzano, Antonio
  • Florez, Jose C.
  • Hansen, Torben
  • Ferrer, Jorge
  • Mercader, Josep M.
  • Torrents, David
The reanalysis of existing GWAS data represents a powerful and cost-effective opportunity to gain insights into the genetics of complex diseases. By reanalyzing publicly available type 2 diabetes (T2D) genome-wide association studies (GWAS) data for 70,127 subjects, we identify seven novel associated regions, five driven by common variants (LYPLAL1, NEUROG3, CAMKK2, ABO, and GIP genes), one by a low-frequency (EHMT2), and one driven by a rare variant in chromosome Xq23, rs146662057, associated with a twofold increased risk for T2D in males. rs146662057 is located within an active enhancer associated with the expression of Angiotensin II Receptor type 2 gene (AGTR2), a modulator of insulin sensitivity, and exhibits allelic specific activity in muscle cells. Beyond providing insights into the genetics and pathophysiology of T2D, these results also underscore the value of reanalyzing publicly available data using novel genetic resources and analytical approaches., This work has been sponsored by the grant SEV-2011-00067 of Severo Ochoa Program, awarded by the Spanish Government. This work was supported by an EFSD/Lilly research fellowship. Josep M. Mercader was supported by Sara Borrell Fellowship from the Instituto Carlos III and Beatriu de Pinós fellowship from the Agency for Management of University and Research Grants (AGAUR). Sílvia Bonàs was FI-DGR Fellowship from FI-DGR 2013 from Agència de Gestió d’Ajuts Universitaris i de Recerca (AGAUR, Generalitat de Catalunya). This study makes use of data generated by the WTCCC. A full list of the investigators who contributed to the generation of the data is available from www.wtccc.org.uk. Funding for the project was provided by the Wellcome Trust under award 076113. This study also makes use of data generated by the UK10K Consortium, derived from samples from UK10K COHORT IMPUTATION (EGAS00001000713). A full list of the investigators who contributed to the generation of the data is available in www.UK10K.org. Funding for UK10K was provided by the Wellcome Trust under award WT091310. We acknowledge PRACE for awarding us to access MareNostrum supercomputer, based in Spain at Barcelona. The technical support group, particularly Pablo Ródenas and Jorge Rodríguez, from the Barcelona Supercomputing Center is gratefully acknowledged. This project has received funding from the European Union’s Horizon 2020 research and innovation program under grant agreement No 667191. Mercè Planas-Fèlix is funded by the Obra Social Fundación la Caixa fellowship under the Severo Ochoa 2013 program. Work from Irene Miguel-Escalada, Ignasi Moran, Goutham Atla, and Jorge Ferrer was supported by the National Institute for Health Research (NIHR) Imperial Biomedical Research Centre, the Wellcome Trust (WT101033), Ministerio de Economía y Competitividad (BFU2014-54284-R) and Horizon 2020 (667191). Irene Miguel-Escalada has received funding from the European Union’s Horizon 2020 research and innovation program under the Marie Sklodowska–Curie grant agreement No 658145. We acknowledge Prof. Giulio Cossu (Institute of Inflammation and Repair, University of Manchester) for providing the muscle myoblast cell line. We also acknowledge the InterAct and SIGMA Type 2 Diabetes Consortia for access to the data to replicate the rs146662075 variant. A full list of the investigators of the SIGMA Type 2 Diabetes and the InterAct consortia is provided in Supplementary Notes 3 and 4. The Novo Nordisk Foundation Center for Basic Metabolic Research is an independent research center at the University of Copenhagen partially funded by an unrestricted donation from the Novo Nordisk Foundation (www.metabol.ku.dk). This research has been conducted using the UK Biobank Resource (application number 16803). We also acknowledge Bianca C. Porneala, MS for his technical assistance in the collection and curation of the genotype and phenotype data from Partners Biobank. We also thank Marcin von Grotthuss for their support for uploading the summary statistics data to the Type 2 Diabetes Genetic Portal (AMP-T2D portal). Finally, we thank all the Computational Genomics group at the BSC for their helpful discussions and valuable comments on the manuscript., Peer Reviewed, Postprint (published version)